1. Home
  2. |Insights
  3. |PODCAST: U.S. Objectives for Negotiating NAFTA — C&M's Trump: The First Year Series

PODCAST: U.S. Objectives for Negotiating NAFTA — C&M's Trump: The First Year Series

Client Alert | 1 min read | 07.28.17

The U.S. released its negotiating objectives for NAFTA on July 17. In the latest podcast for Crowell & Moring’s “Trump: The First Year” series, Robert Holleyman and John Brew, both partners in the firm’s International Trade Group, discuss the objectives and the key takeaways. Robert previously served as Deputy U.S. Trade Representative and as a counsel for the U.S. Senate. John’s practice focuses on customs, and he has extensive experience in import and export trade regulation.

 Discussed in this 17-minute podcast: 

  • An overview of NAFTA.
  • What the U.S. hopes to accomplish in areas such as trade in goods, digital trade, intellectual property, procurement, currency and others.
  • The high stakes around the rules of origin and how revisions may impact the region.
  • How trade remedies will play into NAFTA and what the fate of Chapter 19 dispute resolution might look like.
  • What businesses with operations or trade interests in Mexico and Canada should do now.

Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes

Contacts

Insights

Client Alert | 3 min read | 01.21.26

Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement

On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion....